Skip to content
June 13, 2024First Patient recruited to TenoMiR’s Phase 2 study
Read More
September 26, 2023CAUSEWAY SECURES £8.75 MILLION INVESTMENT
Read More
November 10, 2020Causeway Therapeutics endorsed by Scottish Business Pledge
Read More
September 10, 2020TenoMiR’s human trials start
Read More
July 16, 2020Scottish Enterprise funding
Read More
May 10, 2018Causeway announces Innovate UK grant
Read More
End of content
End of content
